IPO Stock Of The Week and biotech leader Immunocore is within striking distance of a fresh buy point. IMCR stock is a member of the IPO Leaders stock screen. U.K.’s Immunocore sells just one product, Kimmtrak, a melanoma treatment that finds cancer cells through a specific genetic mutation.
